If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Forteo ® (teriparatide injection)
20-mcg daily dose in a 2.4-mL prefilled delivery device
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
FORTEO® (teriparatide injection): Alternate Injection Sites
Forteo should be administered as a subcutaneous injection into the thigh or abdominal wall.
Detailed Information
Teriparatide should be administered as a subcutaneous injection into the thigh or abdominal wall.1
Subcutaneous Injection
In clinical trials, teriparatide was injected subcutaneously into the patient’s thigh or abdominal wall.1
The upper arm is an acceptable area for subcutaneous injection; however, there are no data available on the injection of teriparatide at this site.
Intravenous or Intramuscular Injection
There is no data available on the safety or efficacy of intravenous or intramuscular injection of teriparatide.
Instructions for Teriparatide Injection
Please review the Forteo® Pen User Manual for instructions on how to properly inject teriparatide.
Enclosed Prescribing Information
Reference
1Forteo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: November 11, 2019